Short seller Norris: Covid vaccines are no ‘silver bullet’

Loading player...

Barry Norris, founder and chief executive of Argonaut Capital, tells us why he thinks the market reaction to coronavirus vaccine breakthroughs has been too positive, how short-selling does more good for society than ESG investing, and why he is considering expanding the universe of his European long-only funds to include global stocks.

18 Nov 2020 English United Kingdom Business · Investing

Other recent episodes

Jupiter’s Alex Savvides: ‘It was obvious to everyone there would be outflows’

Nine months into managing the UK Dynamic Equity Fund, Alex Savvides discusses takeover challenges, strategic bids, and where he sees new opportunities.

9 Jul 29 min

IIMI CEO: These are the biggest challenges boutique face

Dani Hristova, CEO of the Independent Investment Management Initiative (IIMI), explains how recent FCA proposals could change the game for boutique firms.

27 May 17 min

Nick Train: The two things my funds need to bounce back

Nick Train discusses buying big into Rightmove, recent ‘pain’ for consumer sector holdings, and how his £1.4bn Finsbury Growth & Income investment trust can return to outperformance.

21 May 19 min

Ex-Aberdeen leader on why wealth firms can't ignore digital assets

As the world of traditional finance and digital assets converge, Duncan Moir, traded a long career at Aberdeen for a role in the digital frontier. In this episode, Moir explains why wealth managers who fail to integrate digital assets into portfolios risk being fundamentally left behind in the race for…

14 May 27 min

Part 2: The FCA answers your questions

When should you challenge clients? What's next for ongoing advice? Nick Hulme answers all your burning questions.

8 May 13 min

All episodes